Thank you for signing!

No Immunity for Glyphosate Manufacturers Facing Cancer Lawsuits

342 signatures toward our 30,000 goal

1.14% Complete

Sponsor: The Breast Cancer Site

Cancer patients and their families deserve their day in court, not a legal shield for glyphosate manufacturers.

No Immunity for Glyphosate Manufacturers Facing Cancer Lawsuits

Tens of thousands of Americans have filed lawsuits alleging that exposure to glyphosate-based herbicides such as Roundup caused non-Hodgkin’s lymphoma. Bayer has proposed a $7.25 billion settlement to resolve many of those claims, but thousands of families still seek accountability through the courts.

A Liability Shield Would Put Companies Above The Public

Instead of protecting the rights of people who say they were harmed, federal action has moved in the opposite direction. Reporting indicates that the government has pushed to support glyphosate production under the Defense Production Act3, raising concern that manufacturers could gain protection from lawsuits tied to cancer claims and warning-label disputes.5

The Right Targets Must Act Now

The EPA Administrator and the EPA Office of Chemical Safety and Pollution Prevention must reject any regulatory stance that weakens public access to the courts. The House Committee on Agriculture and the Senate Committee on Agriculture, Nutrition, and Forestry must also refuse any Farm Bill language that helps pesticide makers escape accountability.2

Health Concerns Still Demand Scrutiny

Scientific and public debate over glyphosate has not gone away. When so many claims remain active and health concerns continue to surface, the answer cannot be less transparency or fewer legal rights. People who believe they were harmed deserve the chance to present their case in court.4

Sign the petition and ask that the EPA and Congress reject any immunity for glyphosate manufacturers facing cancer lawsuits.

More on this issue:

  1. Delger Erdenesanaa, Chemical & Engineering News (3 March 2026), "Farm bill and Trump’s glyphosate order magnify pesticides’ ‘watershed moment’"
  2. Quiver LegislationRadar, Quiver Quantitative (4 March 2026), "New Bill: Representative Thomas Massie introduces H.R. 7601: No Immunity for Glyphosate Act"
  3. Lansing State Journal, Lansing State Journal (20 February 2026), "Herbicide Defense Priority Glyphosate Michigan Farming"
  4. Cassie B., Cancer.news (24 February 2019), "Glyphosate found to attack our immunity: Here’s how to reverse its effects"
  5. Carey Gillam, The New Lede (19 February 2026), "Trump enrages MAHA with order granting “immunity” to glyphosate pesticide production"

The Petition

To the EPA Administrator, EPA Office of Chemical Safety and Pollution Prevention, Members of the House Committee on Agriculture, and Members of the Senate Committee on Agriculture, Nutrition, and Forestry,

I urge you to reject any executive action, Farm Bill provision, regulatory position, or federal policy that would shield glyphosate manufacturers from legitimate cancer lawsuits.

Across the country, tens of thousands of people have filed claims alleging that glyphosate-based herbicides such as Roundup caused non-Hodgkin’s lymphoma. Many of these families have spent years carrying the weight of illness, lost income, medical costs, and grief. They deserve access to the courts, not special protections for the companies they believe harmed them.

This issue now sits at the center of federal pesticide policy. Reporting indicates that recent government action to support glyphosate production under the Defense Production Act could help strengthen liability protections for manufacturers. At the same time, lawmakers have considered Farm Bill language tied to pesticide labeling and legal preemption. These moves raise serious concern that people seeking justice could lose their ability to bring or pursue claims in court.

That must not happen.

The EPA and its Office of Chemical Safety and Pollution Prevention have a duty to protect public health and preserve trust in the regulatory process. Congress, including the House and Senate agriculture committees, has a duty to ensure that federal agricultural policy does not become a vehicle for corporate immunity.

This is not only a legal matter. It is a question of fairness and humanity. When credible health concerns exist and so many families continue to seek accountability, government should not place chemical manufacturers beyond the reach of the courts. If companies are confident in the safety of their products, they should be willing to defend them in court like anyone else.

No family facing cancer should be told that the rules changed after the harm was done. No corporation should receive a special shield because its product is widely used or politically connected. Equal accountability under the law must remain intact.

Please act now to ensure that no executive action, Farm Bill provision, agency position, or federal rule grants immunity or special legal protections to glyphosate manufacturers facing cancer lawsuits.

These actions will ensure a better future for all.

Sincerely,